Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Bioanalysis
|
June 8, 2013
Interview with Dr Bowsher
Ronald R Bowsher
The AAPS Journal
|
October 7, 2020
Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies?
Ronald R Bowsher, Viswanath Devanarayan
Bioanalysis
|
April 23, 2011
Insights in regulated bioanalysis of human insulin and insulin analogs by immunoanalytical methods
Ronald R Bowsher, William L Nowatzke
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 19, 2009
Application of size-exclusion chromatography in the investigation of the in vitro stability of proinsulin and its cleaved metabolites in human serum and plasma
Ronald R Bowsher, Paula F Santa
Neurochemistry International
|
December 25, 2019
Purification, characterization and identification of rat brain cytosolic tyrosine transaminase as glutamine Transaminase-K
Ronald R Bowsher, David P Henry
Journal of Pharmaceutical and Biomedical Analysis
|
November 4, 2008
Insights in the application of research-grade diagnostic kits for biomarker assessments in support of clinical drug development: bioanalysis of circulating concentrations of soluble receptor activator of nuclear factor kappaB ligand
Ronald R Bowsher, Jeffrey M Sailstad
Analytical Methods : Advancing Methods and Applications
|
September 17, 2020
The development, optimization and validation of an ELISA bioanalytical method for the determination of Cetuximab in human serum
Jamil Hantash, Mary Smidt, Ronald R Bowsher
Bioanalysis
|
November 19, 2010
Systematic analytical validation of commercial kits for the determination of novel biomarkers for clinical drug development
William Nowatzke, Thomas G Cole, Ronald R Bowsher
Bioanalysis
|
May 7, 2011
Incurred sample reanalysis: failures in macromolecule analysis--insight into possible causes
Jeffrey M Sailstad, Brent E Salfen, Ronald R Bowsher
The AAPS Journal
|
January 14, 2015
Using DTA and DTAARRAY variables and programming in WinNonlin ASCII models to streamline user-defined calculation and data analysis
Jun Shen, Shuanglian Li, Ronald R Bowsher, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Bioanalysis
|
June 8, 2013
Interview with Dr Bowsher
Ronald R Bowsher
The AAPS Journal
|
October 7, 2020
Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies?
Ronald R Bowsher, Viswanath Devanarayan
Bioanalysis
|
April 23, 2011
Insights in regulated bioanalysis of human insulin and insulin analogs by immunoanalytical methods
Ronald R Bowsher, William L Nowatzke
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 19, 2009
Application of size-exclusion chromatography in the investigation of the in vitro stability of proinsulin and its cleaved metabolites in human serum and plasma
Ronald R Bowsher, Paula F Santa
Neurochemistry International
|
December 25, 2019
Purification, characterization and identification of rat brain cytosolic tyrosine transaminase as glutamine Transaminase-K
Ronald R Bowsher, David P Henry
Journal of Pharmaceutical and Biomedical Analysis
|
November 4, 2008
Insights in the application of research-grade diagnostic kits for biomarker assessments in support of clinical drug development: bioanalysis of circulating concentrations of soluble receptor activator of nuclear factor kappaB ligand
Ronald R Bowsher, Jeffrey M Sailstad
Analytical Methods : Advancing Methods and Applications
|
September 17, 2020
The development, optimization and validation of an ELISA bioanalytical method for the determination of Cetuximab in human serum
Jamil Hantash, Mary Smidt, Ronald R Bowsher
Bioanalysis
|
November 19, 2010
Systematic analytical validation of commercial kits for the determination of novel biomarkers for clinical drug development
William Nowatzke, Thomas G Cole, Ronald R Bowsher
Bioanalysis
|
May 7, 2011
Incurred sample reanalysis: failures in macromolecule analysis--insight into possible causes
Jeffrey M Sailstad, Brent E Salfen, Ronald R Bowsher
The AAPS Journal
|
January 14, 2015
Using DTA and DTAARRAY variables and programming in WinNonlin ASCII models to streamline user-defined calculation and data analysis
Jun Shen, Shuanglian Li, Ronald R Bowsher, et al.
Page
of 4